Skip to main content
. Author manuscript; available in PMC: 2023 Jul 6.
Published in final edited form as: AIDS. 2021 Nov 15;35(14):2399–2401. doi: 10.1097/QAD.0000000000003017

Fig. 1. Anti-SARS-CoV-2 receptor binding domain antibody titres of people with HIV on antiretroviral therapy who underwent two-dose SARS-CoV-2 mRNA vaccination.

Fig. 1.

T1 (titre 1, n = 10) and T2 (titre 2, n = 14) denote anti SARS-CoV-2 RBD titres measured before and 1 month after the second dose of SARS-CoV-2 mRNA vaccination; lines indicate the change in an individual participant’s titre. Assay results could range from <0.4 to >250 U/ml.